NRIX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NRIX shares is 249, representing 97.75% of the company's common stock.

AMERIPRISE FINANCIAL INC, in the last quarter, reduced its stake in NRIX by -4.38% restricting it's holding to 105.86 thousand shares of worth nearly $1.56M. AMERICAN INTERNATIONAL GROUP, INC. also lessened -0.85% of the NRIX shares from its portfolio, reducing its holding to 23.46 thousand shares of worth $344.86K. SG AMERICAS SECURITIES, LLC also shunned NRIX shares holding by -16.57% last quarter which brought its holding to 22.19 thousand shares worth $326.00K.

As per its latest 13F filing, PROFUND ADVISORS LLC increased its stake in NRIX by 100% in the last quarter. The institutional holder raised its holding to 33.06 thousand shares having worth more than $485.98M. MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. also added 27.3% more shares of NRIX to its portfolio, raising its holding to 30.9 thousand shares of worth $315.90K. XTX TOPCO LTD also increased its NRIX shares holding by 123.56% which brought its holding to 26.34 thousand shares worth $387.20K.

The insider with the most stakes in NRIX is Hansen Gwenn , Chief Scientific Officer at the company. Additionally, NRIX stock is highly held by Chief Financial Officer van Houte Hans and Chief Legal Officer Ring Christine among others.

Company executives, directors, and other insiders own 1.45% percent of Nurix Therapeutics, Inc.'s stock. Within the last six months, there have been 18 transaction(s) in which NRIX insiders have sold stock, totaling 76.98K shares. Insiders that have sold shares include RING CHRISTINE, VAN HOUTE HANS, and HANSEN GWENN.

There have been 0 transaction(s) during the past 6-months in which Nurix Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 591.27K Nurix Therapeutics, Inc. shares are held by insiders, which represents about 1.45% of NRIX stock.

NRIX Chief Scientific Officer, Hansen Gwenn holds the largest portfolio of the company's shares. NRIX shares owned by Hansen total nearly 50.67 thousand.

AMERIPRISE FINANCIAL INC is the largest institutional owner in NRIX which holds 105.86 thousand shares worth $1.56M or 0.19% of the total NRIX shares outstanding followed by PROFUND ADVISORS LLC with ownership of 33.06 thousand shares representing 0.06% of the NRIX ownership. MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. is the third largest stakeholder with 30.9 thousand shares or 0.06% of the ownership worth more than $315.90K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NRIX is concerned, it is a stock which is optionable.

Number of NRIX shares short is 10.79M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 70.84M shares of NRIX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NRIX has 57.48M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NRIX is 11.73.